What is BeOne Medicines Ltd. worth?
With the base-case assumptions below, a discounted cash flow model on BeOne Medicines Ltd.'s reported free cash flow gives $24.02 per share. The share price was $367.00 on September 28, 2026, 1,428% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $15.74 | -96% |
| Base | 15.0% | 9.0% | $24.02 | -93% |
| Bull | 20.0% | 8.0% | $39.43 | -89% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $30.29 | $32.24 | $34.63 | $37.62 | $41.45 |
| 8.0% | $25.58 | $26.85 | $28.34 | $30.14 | $32.34 |
| 9.0% | $22.15 | $23.02 | $24.02 | $25.19 | $26.56 |
| 10.0% | $19.55 | $20.17 | $20.87 | $21.67 | $22.59 |
| 11.0% | $17.52 | $17.97 | $18.48 | $19.05 | $19.69 |
Where the presets come from
Base: years 1 to 5 grow at BeOne Medicines Ltd.'s revenue growth rate over the last 5 fiscal years (76.8% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions